Regulating the therapeutic translation of regenerative medicine.
about
Unproven stem cell-based interventions and achieving a compromise policy among the multiple stakeholdersIntegrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come?Stem Cell Research and Clinical Translation: A Roadmap about Good Clinical Practice and Patient Care.Can civil lawsuits stem the tide of direct-to-consumer marketing of unproven stem cell interventions.
P2860
Regulating the therapeutic translation of regenerative medicine.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Regulating the therapeutic translation of regenerative medicine.
@en
Regulating the therapeutic translation of regenerative medicine.
@nl
type
label
Regulating the therapeutic translation of regenerative medicine.
@en
Regulating the therapeutic translation of regenerative medicine.
@nl
prefLabel
Regulating the therapeutic translation of regenerative medicine.
@en
Regulating the therapeutic translation of regenerative medicine.
@nl
P2860
P1476
Regulating the therapeutic translation of regenerative medicine.
@en
P2093
Jackie K Olive
Maude L Cuchiara
P2860
P304
P356
10.1517/14712598.2015.1064895
P407
P50
P577
2015-07-06T00:00:00Z